Wearable technology to monitor paediatric diseases

  • Research type

    Research Study

  • Full title

    Evaluating the use of wearable technology and smart phone apps to monitor paediatric diseases

  • IRAS ID

    174833

  • Contact name

    Paul Gissen

  • Contact email

    p.gissen@ucl.ac.uk

  • Sponsor organisation

    aparito Ltd.

  • Clinicaltrials.gov Identifier

    researchregistry921, www.researchregistry.com

  • Duration of Study in the UK

    2 years, 1 months, 1 days

  • Research summary

    Many children and adults have problems with balance and coordination when they walk because of problems with their bones, muscles, brain or nerves. Even subtle problems may become more troublesome when the child or adult is in more challenging, crowded environments. In some diseases treatments are available to help improve walking and everyday function. To be able to measure the success of treatments, we need to identify the most suitable way to record walking before and after treatment.

    This study plans to compare three different ways of monitoring walking. They are called the 6 Minute Walk Test (6MWT), the GAITRite (a pressure sensing walkway) and wearable technology (a wrist band that monitors movement), this wearable technology will be paired with an app on a patient or parent's phone for additional data capture by questionnaires.

    To find out which one is the best we are inviting children and adults of all ages and abilities to take part. We hope to recruit healthy participants as well as participants that have been diagnosed with various diseases or disorders. We are aiming to record the walking pattern of 100 participants in total. These will be two separate groups are a group of 50 clinical participants with a diagnosis affecting normal development of gait and ambulation, and a normative group of 50 participants with normally developing gait and ambulation.

  • REC name

    London - City & East Research Ethics Committee

  • REC reference

    15/LO/0528

  • Date of REC Opinion

    5 May 2015

  • REC opinion

    Further Information Favourable Opinion